Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Large library docking for novel SARS‐CoV‐2 main protease non‐covalent and covalent inhibitors
Elissa A. Fink, Conner Bardine, Stefan Gahbauer, et al.
Protein Science (2023) Vol. 32, Iss. 8
Open Access | Times Cited: 22

Showing 22 citing articles:

A Comprehensive Survey of Prospective Structure-Based Virtual Screening for Early Drug Discovery in the Past Fifteen Years
Hui Zhu, Yulin Zhang, Wěi Li, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 24, pp. 15961-15961
Open Access | Times Cited: 41
Structure-Based Discovery of Inhibitors of the SARS-CoV-2 Nsp14 N7-Methyltransferase
Isha Singh, Fengling Li, Elissa A. Fink, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 12, pp. 7785-7803
Open Access | Times Cited: 22
Phytochemicals in Drug Discovery—A Confluence of Tradition and Innovation
Patience Chihomvu, A. Ganesan, Simon Gibbons, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 16, pp. 8792-8792
Open Access | Times Cited: 8
On the origins of SARS-CoV-2 main protease inhibitors
Yves L. Janin
RSC Medicinal Chemistry (2023) Vol. 15, Iss. 1, pp. 81-118
Closed Access | Times Cited: 16
Covalent small-molecule inhibitors of SARS-CoV-2 Mpro: Insights into their design, classification, biological activity, and binding interactions
Ahmed M. Shawky, Faisal A. Almalki, Hayat Ali Alzahrani, et al.
European Journal of Medicinal Chemistry (2024) Vol. 277, pp. 116704-116704
Closed Access | Times Cited: 5
Exploring covalent inhibitors of SARS-CoV-2 main protease: from peptidomimetics to novel scaffolds
Noor Atatreh, Radwa E. Mahgoub, Mohammad A. Ghattas
Journal of Enzyme Inhibition and Medicinal Chemistry (2025) Vol. 40, Iss. 1
Open Access
A database for large-scale docking and experimental results
Brendan W. Hall, Tia A. Tummino, Khanh Tang, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Rapid traversal of vast chemical space using machine learning-guided docking screens
Andreas Luttens, Israel Cabeza de Vaca, Leonard Sparring, et al.
Nature Computational Science (2025)
Open Access
Regression-Based Active Learning for Accessible Acceleration of Ultra-Large Library Docking
Egor Marin, Margarita Kovaleva, Maria Kadukova, et al.
Journal of Chemical Information and Modeling (2023) Vol. 64, Iss. 7, pp. 2612-2623
Open Access | Times Cited: 12
Identifying Artifacts from Large Library Docking
Yujin Wu, Fangyu Liu, Isabella Glenn, et al.
Journal of Medicinal Chemistry (2024)
Closed Access | Times Cited: 4
Structure-Based Identification of Organoruthenium Compounds as Nanomolar Antagonists of Cannabinoid Receptors
Qing Wang, Xuegang Fu, Yu‐Ting Yan, et al.
Journal of Chemical Information and Modeling (2024) Vol. 64, Iss. 3, pp. 761-774
Closed Access | Times Cited: 3
Plant flavonoid inhibition of SARS-CoV-2 main protease and viral replication
Lin Lin, Da‐Yuan Chen, Christina Scartelli, et al.
iScience (2023) Vol. 26, Iss. 9, pp. 107602-107602
Open Access | Times Cited: 8
Ensemble docking based virtual screening of SARS‐CoV‐2 main protease inhibitors
Anastasiia D. Fomina, Victoria I. Uvarova, Liubov I. Kozlovskaya, et al.
Molecular Informatics (2024) Vol. 43, Iss. 8
Closed Access | Times Cited: 1
Ultra‐Large Virtual Screening: Definition, Recent Advances, and Challenges in Drug Design
Gabriel Corrêa Veríssimo, Rafaela Salgado Ferreira, Vinícius Gonçalves Maltarollo
Molecular Informatics (2024)
Closed Access | Times Cited: 1
Retrieval Augmented Docking Using Hierarchical Navigable Small Worlds
Brendan W. Hall, Michael J. Keiser
Journal of Chemical Information and Modeling (2024) Vol. 64, Iss. 19, pp. 7398-7408
Open Access | Times Cited: 1
Electrochemical Formation of α-Ketoamides from Ketoximes through Non-Beckmann Mechanism Pathway
Issa Yavari, Sina Shaabanzadeh
The Journal of Organic Chemistry (2024) Vol. 89, Iss. 9, pp. 6238-6246
Closed Access
Identifying Artifacts from Large Library Docking
Yujin Wu, Fangyu Liu, Isabella Glenn, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Are protein–ligand docking programs good enough to predict experimental poses of noncovalent ligands bound to the SARS-CoV-2 main protease?
Ariadna Llop-Peiró, Guillem Macip, Santiago Garcı́a-Vallvé, et al.
Drug Discovery Today (2024) Vol. 29, Iss. 10, pp. 104137-104137
Open Access
SpaceHASTEN: A Structure-Based Virtual Screening Tool for Nonenumerated Virtual Chemical Libraries
Tuomo Kalliokoski, Ainoleena Turku, Heikki Käsnänen
Journal of Chemical Information and Modeling (2024) Vol. 65, Iss. 1, pp. 125-132
Closed Access
Molecular Modeling Strategies in Drug Design, Development, and Discovery Targeting Proteases
Viviane Corrêa Santos, Lucas Abreu Diniz, Rafaela Salgado Ferreira
(2024), pp. 435-461
Closed Access
A Prototype Assay Multiplexing SARS-CoV-2 3CL-Protease and Angiotensin-Converting Enzyme 2 for Saliva-Based Diagnostics in COVID-19
Vallabh Suresh, Daniel A. Sheik, Tyler C. Detomasi, et al.
Biosensors (2023) Vol. 13, Iss. 7, pp. 682-682
Open Access | Times Cited: 1
Page 1

Scroll to top